Levetiracetam Qualigen (Levetiracetam)

Levetiracetam is an antiepileptic drug that acts on neuronal excitability to control various seizure disorders.

• Epilepsy: reduces overall seizure frequency across multiple seizure types.
• Partial seizures: controls focal onset seizures with or without secondary generalization.
• Myoclonic seizures: diminishes sudden, brief muscle jerks.
• Primary generalized tonic‑clonic seizures: prevents generalized convulsive episodes.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal firing. This interaction reduces excessive neuronal excitability, thereby decreasing the likelihood of seizure initiation and propagation without directly influencing ion channels or GABA receptors.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects

• Drowsiness: feeling unusually sleepy.
• Fatigue: reduced energy levels.
• Dizziness: sensation of light‑headedness.
• Headache: mild to moderate cranial pain.
• Irritability: increased mood volatility.
• Nausea: upset stomach.

Serious or Rare Side Effects

• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Mood changes: including depression or suicidal thoughts.
• Allergic reactions: rash, swelling, or anaphylaxis.
• Blood disorders: rare cases of leukopenia or thrombocytopenia.
• Multi‑organ hypersensitivity: systemic inflammatory response.
• Hepatic dysfunction: abnormal liver enzymes.

Levetiracetam requires careful consideration of patient‑specific factors before use.

• Renal impairment: dose adjustment may be needed.
• Hepatic impairment: monitor liver function.
• Pregnancy: risk unknown; weigh benefits against potential risks.
• Discontinuation: avoid abrupt stopping; taper under medical supervision.
• Concomitant CNS depressants: monitor for enhanced sedation.
• Store at room temperature: keep in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Carbamazepine: enzyme induction reduces levetiracetam levels.
• Phenytoin: decreases levetiracetam plasma concentration.
• Phenobarbital: lowers levetiracetam exposure.

Moderate Interactions (Monitor Closely)

• Alcohol: may increase central nervous system depression.
• Other CNS depressants: enhanced drowsiness.
• Fluoroquinolone antibiotics: potential increase in neuropsychiatric effects.
• NSAIDs: monitor for renal function.
• Certain antidepressants: watch for mood alterations.